Recent advances in the discovery and development of plant-derived natural coumarins and their analogues as anti human immunodeficiency virus—type 1 (hiv-1) agents

Biotechnology and Biotechnological Equipment

Volumn 19, Issue 1, 2005, Pages 16-22

  Kostova, I ^a   Raleva, S ^b   Genova, P ^c   Argirova, R ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^c UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

12 METHOXYCALANOLIDE B; 12 METHOXYCALANOLIDE C; 3' ACETOXY 4' (ISOVALERYLOXY) 3',4' DIHYDROSESELIN; 3',4' DI O CAMPHONYLKHELLACTONE; 5 HYDROXY 6 METHOXY 7 (3 METHYLBUT 2 ENYLOXY) 2H 1 BENZOPYRAN 2 ONE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ARTEMICAPIN A; ARTEMICAPIN B; ARTEMICAPIN C; ARTEMICAPIN D; ARTEMISIDIN A; CALANOLIDE A; CORDATOLIDE A; CORDATOLIDE B; COSTATOLIDE; COUMARIN DERIVATIVE; DICOUMAROL; DIHYDROCOSTATOLIDE; FESUMTUORIN A; FESUMTUORIN B; FESUMTUORIN C; FESUMTUORIN D; FESUMTUORIN E; FLAVONOID; INOPHYLLUM B; INOPHYLLUM P; PYRANOCOUMARIN DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALTERNATIVE MEDICINE; ANTIVIRAL ACTIVITY; ARTEMISIA CAPILLARIS; CALOPHYLLUM CERASIFERUM; CALOPHYLLUM CORDATO OBLONGUM; CALOPHYLLUM LANIGERUM; CHINESE MEDICINE; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG SCREENING; FERULA SUMBUL; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LOMATIUM SUKSDORFII; MEDICINAL PLANT; NONHUMAN; PRANGOS TSCHIMGANICA; PSIADIA DENTATA; REVIEW; STOMACH DISEASE; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS REPLICATION;

ARTEMISIA CAPILLARIS; CALOPHYLLUM; CALOPHYLLUM CERASIFERUM; CALOPHYLLUM CORDATO; CALOPHYLLUM CORDATO-OBLONGUM; CALOPHYLLUM LANIGERUM; FERULA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LOMATIUM SUKSDORFII; PRANGOS; PSIADIA; PSIADIA DENTATA;

EID: 13844271394     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2005.10817148     Document Type: Article

References (42)

1. Boyer P.L., Currens M.J., McMahon J.B., Boyd M.R., Hughes S.H., (1993) J. Virol., 67, 2412–2420.
2. Buckheit R.W., Kilnjerski T.L., Fliakas-Boltz V., Russell J.D., Stup T.L., Palansch L.A., Brouwer W.G., Dao D.C., Harrison W.A., Schultz R.J., Bader J.P., Yang S.S., (1995) Antimicrob. Agents. Chemother., 39, 2718–2727.
3. Buckheit R.W., Fliakas-Boltz V., Yeagy-Bargo S., Weislow O., Mayers D.L., Boyer P.L., Hughes S.H., Pan B.C., Chu S.H., Bader J.P., (1995) Virology, 210, 186–193.
4. Buckheit R.W., White E.L., Fliakas-Boltz V., Russell J., Stup T.L., Kinjerski T.L., Ostering M.C., Weigand A., Bader J.P., (1999) Antimicrob. Agents Chemother., 43, 1827–1834.
5. Buckheit R.W., Fliakas-Boltz V., Decker W.D., Roberson J.L., Stup T.L., Pyle C.A., White E.L., McMahon J.B., Currens M.J., Boyd M.R., Bader J.P., (1995) Antiviral Res., 26, 117–132.
6. Buckheit R.W., Fliakas-Boltz V., Decker W.D., Roberson J.L., Pyle C.A., White E.L., Bowdon B.J., McMahon J.B., Boyd M.R., Bader J.P., Nickell D.G., Barth H., Antonucci T.K., (1994) Antiviral Res., 25, 43–56.
7. Currens M.J., Gulakowski R.J., Mariner J.M., Moran R.A., Buckheit R.W., Jr, Gustafson K.R., McMahon J.B., Boyd M.R., (1996) J. Pharmacol. Exp. Ther., 279, 645–651.
8. Currens M.J., Mariner J.M., McMahon J.B., Boyd M.R., (1996) J. Pharmacol. Exp. Ther., 279, 652–661.
9. Dharmaratne H.R., Wanigasekera W.M., Mata-Greenwood E., Pezzuto J.M., (1998) Planta Med., 64, 460–461.
10. Dharmaratne H.R., Tan G.T., Marasinghe G.P., Pezzuto J.M., (2002) Planta Med., 68, 86–87.
11. Dharmaratne H.R., Mayuri Sajeevani J.R., Marasinghe G.P., Shantha Ekanayake E.M., (1998) Phytochemistry, 49, 995–998.
12. Flavin M.T., Rizzo J.D., Khilevich A., Kucherenko A., Sheinkman A.K., Vilaychack V., Lin L., Chen W., Greenwood M.E., Pengsuparp T., Pezzuto J.M., Hughes S.H., Flavin T.M., Cibulski M., Boulanger W.A., Shone R.L., Xu Z.Q., (1996) J. Med. Chem., 39, 1303–1313.
13. Fortin H., Tomasi S., Jaccard P., Robin V., Boustie J., (2001) Chem. Pharm. Bull. (Tokyo), 49, 619–621.
14. Fuller R.W., Bokesch H.R., Gustafson K.R., McKee T.C., Cardellina J.H., McMahon J.B., Cragg G.M., Soejarto D.D., Boyd M.R., (1994) BioMed. Chem. Lett., 4, 1961–1964.
15. Gustafson K.R., (1994) Tetrahedron Lett., 35, 5821–5824.
16. Hizi A., Tal R., Shaharabany M., Currens M.J., Boyd M.R., Hughes S.H., McMahon J.B., (1993) Antimicrob. Agents Chemother., 37, 1037–1042.
17. Kashman Y., Gustafson K.R., Fuller R.W., Cardellina J.H., McMahon J.B., Currens M.J., Buckheit R.W., Hughes S.H., Cragg G.M., Boyd M.R., (1992) J. Med. Chem., 35, 2735–2743.
18. Lee T.T., Kashiwada Y., Huang L., Snider J., Cosentino M., Lee K.H., (1994) Bioorg. Med. Chem., 2, 1051–1056.
19. Lee K.H., Morris-Natschke S.L., (1999) Pure Appl. Chem., 71, 53–57.
20. Lin Y.M., Anderson H.M., Jenta T.R., Williams M.J., Flavin M.T., Xu Z.Q., (1999) Pharmaceutical Biology, 37, 71–76.
21. McKee T.C., Covington C.D., Fuller R.W., Bokesch H.R., Young S., Cardellina J.H., Kadushin M.R., Soejarto D.D., Stevens P.F., Cragg G.M., Boyd M.R., (1998) J. Nat. Prod., 61, 1252–1256.
22. McKee T.C., Fuller R.W., Covington C.D., Cardellina J.H., Gulakowski R.J., Krepps B.L., McMahon J.B., Boyd M.R., (1996) J. Nat. Prod., 59, 754–758.
23. Newman R.A., Chen W., Madden T.L., (1998) J. Pharm. Sci., 87, 1077–1080.
24. Patil A.D., Freyer A.J., Eggleston D.S., Haltiwanger R.C., Bean M.F., Taylor P.B., Caranfa M.J., Breen A.L., Bartus H.R., Johnson R.K., Hertzberg R.P., Westley J.W., (1993) J. Med. Chem., 36, 4131–4138.
25. Pengsuparp T., Serit M., Hughes S.H., Soejarto D.D., Pezzuto J.M., (1996) J. Nat. Prod., 59, 839–842.
26. Quan Y., Motakis D., Buckheit R.W., Xu Z.Q., Flavin M.T., Parniak M.A., Wainberg M.A., (1999) Antiviral Therapy, 4, 203–209.
27. Rader R.A., (2000) Antiviral Agents Bulletin., 13, 37–41.
28. Ravelonjato B., Libot F., Ramiandrasoa F., (1992) Planta Med., 58, 51–55.
29. Robert W., Buckheit Jr., Russell J.D., Xu Z.Q., Flavin M.T., (2000) Antiviral Chemistry and Chemotherapy, 11, 321–327.
30. Shikishima Y., Takaishi Y., Honda G., (2001) Chem. Pharm. Bull. (Tokyo), 49, 877–880.
31. Sorbera L.A., Leeson P., Castaner J., (1999) Drugs of the Future, 24, 235–245.
32. Spino C., Dodier M., Sotheeswaran S., (1998) Bioorg. Med. Chem. Lett., 8, 3475–3478.
33. Taylor P.B., Culp J.S., Debouck C., (1994) J. Biol. Chem., 269, 6325–6331.
34. Terri C., Ruckle J.L., Dwain Tolbert D., Giltner J., David A., Eiznhamer B.D., Flavin M.T., Xu Z.Q., (2001) Antimicrobial Agents and Chemotherapy, 45, 1379–1386.
35. Trost B.M., Toste F.D., (1998) J. Am. Chem. Soc., 120, 9074–9075.
36. Vlietinck A.J., De Bruyne T., Apers S., Pieters L.A., (1998) Planta Med., 64, 97–109.
37. Wang H.X., Ng T.B., (2001) Planta Med., 67, 669–672.
38. Wu T.S., Tsang Z.J., Wu P.L., Lin F.W., Li C.Y., Teng C.M., Lee K.H., (2001) Bioorg. Med. Chem., 9, 77–83.
39. Xu Z.Q., Hollingshead M.G., Gorgel S., Elder C., Khilevich A., Flavin M.T., (1999) Bioorg. Med. Chem. Lett., 9, 133–138.
40. Xu Z.Q., Norris K.J., Weinberg D.S., Kardatze J., Wertz P., Frank P., Flavin M. T., (2000) J. Chromatography, 742, 267–275.
41. Xu Z.Q., Jenta T.R., Flavin M.T., (2000) Current Opinion for Drug Discovery & Development, 3, 155–166.
42. Zhou P., Takaishi Y., Duan H., Chen B., Honda G., Itoh M., Takeda Y., Kodzhimatov O.K., Lee K.H., (2000) Phytochemistry, 53, 689–697.